MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
Launched by HEALTHTREE FOUNDATION · Jan 26, 2021
Trial Information
Current as of April 30, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (greater than 18 years) diagnosed with MGUS, smoldering myeloma, and multiple myeloma.
- • Access to a computer or electronic device with internet access, or phone
- • Willing to create a patient profile on the HealthTree Cure Hub For Multiple Myeloma
- • Willing to give electronically-signed consent
- • Ability to read questions in English
About Healthtree Foundation
HealthTree Foundation is a leading nonprofit organization dedicated to advancing research and improving outcomes for patients with blood cancers, including multiple myeloma and related disorders. By fostering collaboration among patients, researchers, and healthcare professionals, the foundation aims to accelerate the development of innovative treatment options and enhance patient education and support. Through its robust clinical trial initiatives, HealthTree Foundation empowers patients to participate actively in research and contributes to the collective knowledge that drives breakthroughs in cancer care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lehi, Utah, United States
Patients applied
Trial Officials
Nathan Sweeney, PhD
Study Chair
HealthTree Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials